A citation-based method for searching scientific literature

Jérémie Nsengimana, Jon Laye, Anastasia Filia, Christy Walker, Rosalyn Jewell, Joost J Van den Oord, Pascal Wolter, Poulam Patel, Antje Sucker, Dirk Schadendorf, Göran B Jönsson, D Timothy Bishop, Julia Newton-Bishop. Oncotarget 2015
Times Cited: 33







List of co-cited articles
191 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome.
Göran Jönsson, Christian Busch, Stian Knappskog, Jürgen Geisler, Hrvoje Miletic, Markus Ringnér, Johan R Lillehaug, Ake Borg, Per Eystein Lønning. Clin Cancer Res 2010
155
33

Molecular profiling reveals low- and high-grade forms of primary melanoma.
Katja Harbst, Johan Staaf, Martin Lauss, Anna Karlsson, Anna Måsbäck, Iva Johansson, Pär-Ola Bendahl, Johan Vallon-Christersson, Therese Törngren, Henrik Ekedahl,[...]. Clin Cancer Res 2012
68
30

Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy.
Helena Cirenajwis, Henrik Ekedahl, Martin Lauss, Katja Harbst, Ana Carneiro, Jens Enoksson, Frida Rosengren, Linda Werner-Hartman, Therese Törngren, Anders Kvist,[...]. Oncotarget 2015
89
30

Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma.
Pedram Gerami, Robert W Cook, Jeff Wilkinson, Maria C Russell, Navneet Dhillon, Rodabe N Amaria, Rene Gonzalez, Stephen Lyle, Clare E Johnson, Kristen M Oelschlager,[...]. Clin Cancer Res 2015
132
27

Final version of 2009 AJCC melanoma staging and classification.
Charles M Balch, Jeffrey E Gershenwald, Seng-Jaw Soong, John F Thompson, Michael B Atkins, David R Byrd, Antonio C Buzaid, Alistair J Cochran, Daniel G Coit, Shouluan Ding,[...]. J Clin Oncol 2009
24

Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma.
Julia A Newton-Bishop, Samantha Beswick, Juliette Randerson-Moor, Yu-Mei Chang, Paul Affleck, Faye Elliott, May Chan, Susan Leake, Birute Karpavicius, Sue Haynes,[...]. J Clin Oncol 2009
190
21

Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Véronique Winnepenninckx, Vladimir Lazar, Stefan Michiels, Philippe Dessen, Marguerite Stas, Soledad R Alonso, Marie-Françoise Avril, Pablo L Ortiz Romero, Thomas Robert, Ovidiu Balacescu,[...]. J Natl Cancer Inst 2006
367
18

A nine-gene signature predicting clinical outcome in cutaneous melanoma.
G Brunner, M Reitz, A Heinecke, A Lippold, C Berking, L Suter, J Atzpodien. J Cancer Res Clin Oncol 2013
40
18

Consensus of Melanoma Gene Expression Subtypes Converges on Biological Entities.
Martin Lauss, Jeremie Nsengimana, Johan Staaf, Julia Newton-Bishop, Göran Jönsson. J Invest Dermatol 2016
14
42

Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy.
Pedram Gerami, Robert W Cook, Maria C Russell, Jeff Wilkinson, Rodabe N Amaria, Rene Gonzalez, Stephen Lyle, Gilchrist L Jackson, Anthony J Greisinger, Clare E Johnson,[...]. J Am Acad Dermatol 2015
91
15

Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq.
Itay Tirosh, Benjamin Izar, Sanjay M Prakadan, Marc H Wadsworth, Daniel Treacy, John J Trombetta, Asaf Rotem, Christopher Rodman, Christine Lian, George Murphy,[...]. Science 2016
15

Model predicting survival in stage I melanoma based on tumor progression.
W H Clark, D E Elder, D Guerry, L E Braitman, B J Trock, D Schultz, M Synnestvedt, A C Halpern. J Natl Cancer Inst 1989
914
15

β-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomas.
Jérémie Nsengimana, Jon Laye, Anastasia Filia, Sally O'Shea, Sathya Muralidhar, Joanna Poźniak, Alastair Droop, May Chan, Christy Walker, Louise Parkinson,[...]. J Clin Invest 2018
36
15

Distinct sets of genetic alterations in melanoma.
John A Curtin, Jane Fridlyand, Toshiro Kageshita, Hetal N Patel, Klaus J Busam, Heinz Kutzner, Kwang-Hyun Cho, Setsuya Aiba, Eva-Bettina Bröcker, Philip E LeBoit,[...]. N Engl J Med 2005
12

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
James Larkin, Vanna Chiarion-Sileni, Rene Gonzalez, Jean Jacques Grob, C Lance Cowey, Christopher D Lao, Dirk Schadendorf, Reinhard Dummer, Michael Smylie, Piotr Rutkowski,[...]. N Engl J Med 2015
12

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park,[...]. N Engl J Med 2004
12

The clinicopathological and gene expression patterns associated with ulceration of primary melanoma.
Rosalyn Jewell, Faye Elliott, Jonathan Laye, Jérémie Nsengimana, John Davies, Christy Walker, Caroline Conway, Angana Mitra, Mark Harland, Martin G Cook,[...]. Pigment Cell Melanoma Res 2015
22
18

The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis.
Adam I Riker, Steven A Enkemann, Oystein Fodstad, Suhu Liu, Suping Ren, Christopher Morris, Yaguang Xi, Paul Howell, Brandon Metge, Rajeev S Samant,[...]. BMC Med Genomics 2008
344
12

A landscape of driver mutations in melanoma.
Eran Hodis, Ian R Watson, Gregory V Kryukov, Stefan T Arold, Marcin Imielinski, Jean-Philippe Theurillat, Elizabeth Nickerson, Daniel Auclair, Liren Li, Chelsea Place,[...]. Cell 2012
12

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.
Da Wei Huang, Brad T Sherman, Richard A Lempicki. Nat Protoc 2009
12

Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity.
Stefani Spranger, Riyue Bao, Thomas F Gajewski. Nature 2015
12

The Genetic Evolution of Melanoma from Precursor Lesions.
A Hunter Shain, Iwei Yeh, Ivanka Kovalyshyn, Aravindhan Sriharan, Eric Talevich, Alexander Gagnon, Reinhard Dummer, Jeffrey North, Laura Pincus, Beth Ruben,[...]. N Engl J Med 2015
459
12

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
Jedd D Wolchok, Vanna Chiarion-Sileni, Rene Gonzalez, Piotr Rutkowski, Jean-Jacques Grob, C Lance Cowey, Christopher D Lao, John Wagstaff, Dirk Schadendorf, Pier F Ferrucci,[...]. N Engl J Med 2017
12

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.
Jeffrey Weber, Mario Mandala, Michele Del Vecchio, Helen J Gogas, Ana M Arance, C Lance Cowey, Stéphane Dalle, Michael Schenker, Vanna Chiarion-Sileni, Ivan Marquez-Rodas,[...]. N Engl J Med 2017
939
12

Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy.
Alexander M M Eggermont, Vanna Chiarion-Sileni, Jean-Jacques Grob, Reinhard Dummer, Jedd D Wolchok, Henrik Schmidt, Omid Hamid, Caroline Robert, Paolo A Ascierto, Jon M Richards,[...]. N Engl J Med 2016
721
12

A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms.
Pedram Gerami, Gu Li, Pedram Pouryazdanparast, Beth Blondin, Beth Beilfuss, Carl Slenk, Jing Du, Joan Guitart, Susan Jewell, Katerina Pestova. Am J Surg Pathol 2012
112
9

Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases.
Beatrice Vergier, Martina Prochazkova-Carlotti, Arnaud de la Fouchardière, Lorenzo Cerroni, Daniela Massi, Vincenzo De Giorgi, Christiane Bailly, Ulrich Wesselmann, Apollon Karlseladze, Marie-Francoise Avril,[...]. Mod Pathol 2011
94
9

Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma.
Loren E Clarke, M B Warf, Darl D Flake, Anne-Renee Hartman, Steven Tahan, Christopher R Shea, Pedram Gerami, Jane Messina, Scott R Florell, Richard J Wenstrup,[...]. J Cutan Pathol 2015
73
9

Final trial report of sentinel-node biopsy versus nodal observation in melanoma.
Donald L Morton, John F Thompson, Alistair J Cochran, Nicola Mozzillo, Omgo E Nieweg, Daniel F Roses, Harold J Hoekstra, Constantine P Karakousis, Christopher A Puleo, Brendon J Coventry,[...]. N Engl J Med 2014
758
9

Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma.
Pedram Gerami, Susan S Jewell, Larry E Morrison, Beth Blondin, John Schulz, Teresa Ruffalo, Paul Matushek, Mona Legator, Kristine Jacobson, Scott R Dalton,[...]. Am J Surg Pathol 2009
289
9

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma.
Eliezer M Van Allen, Diana Miao, Bastian Schilling, Sachet A Shukla, Christian Blank, Lisa Zimmer, Antje Sucker, Uwe Hillen, Marnix H Geukes Foppen, Simone M Goldinger,[...]. Science 2015
9

25-Hydroxyvitamin D2 /D3 levels and factors associated with systemic inflammation and melanoma survival in the Leeds Melanoma Cohort.
Julia A Newton-Bishop, John R Davies, Faheem Latheef, Juliette Randerson-Moor, May Chan, Jo Gascoyne, Saila Waseem, Susan Haynes, Charles O'Donovan, D Timothy Bishop. Int J Cancer 2015
34
9

Association of Vitamin D Levels With Outcome in Patients With Melanoma After Adjustment For C-Reactive Protein.
Shenying Fang, Dawen Sui, Yuling Wang, Huey Liu, Yi-Ju Chiang, Merrick I Ross, Jeffrey E Gershenwald, Janice N Cormier, Richard E Royal, Anthony Lucci,[...]. J Clin Oncol 2016
33
9

Serum 25-hydroxyvitamin D serum levels in a large German cohort of patients with melanoma.
T Gambichler, M Bindsteiner, S Höxtermann, A Kreuter. Br J Dermatol 2013
33
9


An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background.
Devarati Mitra, Xi Luo, Ann Morgan, Jin Wang, Mai P Hoang, Jennifer Lo, Candace R Guerrero, Jochen K Lennerz, Martin C Mihm, Jennifer A Wargo,[...]. Nature 2012
262
9

The gene expression signatures of melanoma progression.
Christopher Haqq, Mehdi Nosrati, Daniel Sudilovsky, Julia Crothers, Daniel Khodabakhsh, Brian L Pulliam, Scot Federman, James R Miller, Robert E Allen, Mark I Singer,[...]. Proc Natl Acad Sci U S A 2005
313
9

Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.
M Ashburner, C A Ball, J A Blake, D Botstein, H Butler, J M Cherry, A P Davis, K Dolinski, S S Dwight, J T Eppig,[...]. Nat Genet 2000
9

Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.
Christine Guo Lian, Yufei Xu, Craig Ceol, Feizhen Wu, Allison Larson, Karen Dresser, Wenqi Xu, Li Tan, Yeguang Hu, Qian Zhan,[...]. Cell 2012
498
9

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.
Michael Krauthammer, Yong Kong, Byung Hak Ha, Perry Evans, Antonella Bacchiocchi, James P McCusker, Elaine Cheng, Matthew J Davis, Gerald Goh, Murim Choi,[...]. Nat Genet 2012
763
9

STAR: ultrafast universal RNA-seq aligner.
Alexander Dobin, Carrie A Davis, Felix Schlesinger, Jorg Drenkow, Chris Zaleski, Sonali Jha, Philippe Batut, Mark Chaisson, Thomas R Gingeras. Bioinformatics 2013
9

High frequency of BRAF mutations in nevi.
Pamela M Pollock, Ursula L Harper, Katherine S Hansen, Laura M Yudt, Mitchell Stark, Christiane M Robbins, Tracy Y Moses, Galen Hostetter, Urs Wagner, John Kakareka,[...]. Nat Genet 2003
9

Improved survival with ipilimumab in patients with metastatic melanoma.
F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel,[...]. N Engl J Med 2010
9

Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53.
Amaya Viros, Berta Sanchez-Laorden, Malin Pedersen, Simon J Furney, Joel Rae, Kate Hogan, Sarah Ejiama, Maria Romina Girotti, Martin Cook, Nathalie Dhomen,[...]. Nature 2014
125
9

Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
Levi A Garraway, Hans R Widlund, Mark A Rubin, Gad Getz, Aaron J Berger, Sridhar Ramaswamy, Rameen Beroukhim, Danny A Milner, Scott R Granter, Jinyan Du,[...]. Nature 2005
9

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.
Keith T Flaherty, Jeffery R Infante, Adil Daud, Rene Gonzalez, Richard F Kefford, Jeffrey Sosman, Omid Hamid, Lynn Schuchter, Jonathan Cebon, Nageatte Ibrahim,[...]. N Engl J Med 2012
9

Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma.
Judith Müller, Oscar Krijgsman, Jennifer Tsoi, Lidia Robert, Willy Hugo, Chunying Song, Xiangju Kong, Patricia A Possik, Paulien D M Cornelissen-Steijger, Marnix H Geukes Foppen,[...]. Nat Commun 2014
303
9

MITF-High and MITF-Low Cells and a Novel Subpopulation Expressing Genes of Both Cell States Contribute to Intra- and Intertumoral Heterogeneity of Primary Melanoma.
Marie Ennen, Céline Keime, Giovanni Gambi, Alice Kieny, Sebastien Coassolo, Christelle Thibault-Carpentier, Fanny Margerin-Schaller, Guillaume Davidson, Constance Vagne, Dan Lipsker,[...]. Clin Cancer Res 2017
30
10

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.
Georgina V Long, Axel Hauschild, Mario Santinami, Victoria Atkinson, Mario Mandalà, Vanna Chiarion-Sileni, James Larkin, Marta Nyakas, Caroline Dutriaux, Andrew Haydon,[...]. N Engl J Med 2017
620
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.